Translate Bio Inc.

(TBIO) Trade

Symbol has changed to a new ticker symbol

(TBIOD)

By |

Profile

Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.

Contact Information

Website: www.translate.bio
Email: tdahlman@translate.bio
Main Phone: +1 617 945-7361
Address: 29 Hartwell Avenue
State: MA
City / Town: Lexington
Country: USA
Postal Code: 02421

Issuer Information

Exchange: NGS
CEO: Ronald C. Renaud
Employees: 61
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 9.00 $ -0.06 (-0.66%)
Last Price 9.00 Change $ -0.06 Change % -0.66 Tick N/A
Bid 9.01 Bid Size 800.00 Ask 14.00 Ask Size 100.00
Open 9.19 High 10.33 Low 8.99 Prev Close 9.06
Last Trade Volume 80,671 52 Wk Hi 16.60 52 Wk Low 5.00
Market Cap 406.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 45,141,690.00 EPS (TTM) -6.75 PE Ratio N/A Exchange NGS